Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06313606 · ClinicalTrials.gov registry record · NA
Sparking Gut Bacteria Production of Bioactive Xenolipids in Situ
A NA study of Dietary Fat Metabolism, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06313606: Recruiting NA study of Dietary Fat Metabolism, sponsored by University of California, Davis.
NCT06313606 is a NA study of Dietary Fat Metabolism that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06313606, a NA study of Dietary Fat Metabolism, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Long-chain cyclopropane fatty acids (CpFAs) are microbially-derived lipids (fats), some of which can be found in select foods and appear to be produced naturally in the gut from dietary fatty acid precursors. Some of these lipids appear to have signaling properties in the body's tissues, i.e., to help regulate cardiometabolic health. Thus, increasing the bioavailability of CpFAs in humans may have utility to improve management of blood sugar and blood lipids, or to mitigate or prevent non-alcoholic fatty liver disease (NAFLD). This study is a proof-of-principle experiment in 10 subjects, to feed dietary fats thought to enhance upper gut CpFA production. The latter will be monitored through post-meal blood and urine CpFA concentration measurements, as well as concentration in the stool.
Primary Outcome
Change in blood, urine, or gastrointestinal (stool) CpFA fatty acids following dietary fat intake
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Dietary fat positive control
- DIETARY_SUPPLEMENT Dietary fat negative control
Study Locations (1)
California
- University of California, Davis School of Medicine - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What NCT06313606 shows while recruiting
NCT06313606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Dietary Fat Metabolism appearing as the primary indexed condition, and to 2 interventions - of which Dietary fat positive control is the first listed.
NCT06313606 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06313606 about?
NCT06313606 is a clinical study titled "Sparking Gut Bacteria Production of Bioactive Xenolipids in Situ". Long-chain cyclopropane fatty acids (CpFAs) are microbially-derived lipids (fats), some of which can be found in select foods and appear to be produced naturally in the gut from dietary fatty acid precursors. Some of these lipids appear to have signaling properties in the body's tissues, i.e., to he...
What is the current status of trial NCT06313606?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-04-01. Estimated completion is 2025-05-31.
What conditions does trial NCT06313606 study?
This clinical trial studies the following conditions: Dietary Fat Metabolism.
What interventions are being tested in trial NCT06313606?
The interventions under investigation include: Dietary fat positive control (DIETARY_SUPPLEMENT), Dietary fat negative control (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06313606?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06313606 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06313606's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI